Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs Intramuscular BTXA for Facial Aging
NCT02907268Phase 2Completed
- Sponsor
- Institute of Cosmetic and Laser Surgery
- Start
- Sep 2013
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, single-blind trial of botulinum toxin type A in facial rhytids (2 arms), sponsored by Institute of Cosmetic and Laser Surgery. Primary endpoint: Overall Change in Facial Wrinkles From Baseline at 16 weeks. Started Sep 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
facial rhytids
Beyond the preview
Go deeper on NCT02907268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907268.